ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,574Medicare Part D Prescriptions Filled, Including Refills

Rank: 256 out of 676

$530K Total Retail Price of All Prescriptions

Rank: 203 out of 676

212 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
61% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Mississippi
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

14% of this provider’s 212 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

0% of this provider’s 6,591 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

33% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

40 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
SIMVASTATIN 398 352 1 6
AMLODIPINE BESYLATE 334 294 2 3
PANTOPRAZOLE SODIUM 332 261 3 42
LEVOTHYROXINE SODIUM 253 232 4 7
CARVEDILOL 200 171 5 15
ATORVASTATIN CALCIUM 190 118 6 20
OMEPRAZOLE 182 152 7 2
GABAPENTIN 181 164 8 10
GLIMEPIRIDE 180 141 9 30
HYDROCODONE-ACETAMINOPHEN 180 151 S3 9 1
METFORMIN HCL 174 122 11 8
TRAMADOL HCL 173 148 12 19
LISINOPRIL 153 104 13 5
FUROSEMIDE 136 116 14 4
LOSARTAN POTASSIUM 133 121 15 34
AMLODIPINE BESYLATE-BENAZEPRIL 132 120 16 44
NEXIUM 131 91 17 23
CRESTOR 127 93 18 29
DIOVAN 116 82 19 37
HYDROCHLOROTHIAZIDE 115 86 20 12
METOPROLOL SUCCINATE 111 81 21 14
CYMBALTA 110 70 22 47
FLUTICASONE PROPIONATE 102 83 23 49
POTASSIUM CHLORIDE 95 89 24 9
ALLOPURINOL 94 81 25 31
CLOPIDOGREL 88 66 26 28
SYNTHROID 86 66 27 48
SPIRIVA 85 39 28 97
MIRTAZAPINE 81 74 29 59
CITALOPRAM HBR 76 65 30 17
LANTUS SOLOSTAR 76 50 30 169
METOPROLOL TARTRATE 76 57 30 22
PRAVASTATIN SODIUM 74 58 33 11
BACLOFEN 72 48 34 144
ADVAIR DISKUS 69 47 35 87
LISINOPRIL-HYDROCHLOROTHIAZIDE 67 62 36 16
ZOLPIDEM TARTRATE 66 48 37 21
ISOSORBIDE MONONITRATE ER 65 64 38 54
PLAVIX 63 52 39 40
VENLAFAXINE HCL ER 62 53 40 98
WARFARIN SODIUM 62 47 40 18
SPIRONOLACTONE 61 49 42 62
JANUVIA 59 34 43 78
LYRICA 57 30 44 57
LOVAZA 57 11 44 183
EXFORGE 55 53 46 132
DIOVAN HCT 54 52 47 41
METFORMIN HCL ER 53 38 48 63
PROAIR HFA 52 25 49 79
JANUMET 51 39 50 167
TAMSULOSIN HCL 51 44 50 38
VESICARE 50 49 52 201
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 26, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.